Furthermore, pentraxin 3 (PTX-3) was suggested as a marker of fibrosis in metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH). Here, PTX3 is linked to metabolic dysfunction-associated steatohepatitis.